NasdaqGM - Nasdaq Real Time Price USD

Verrica Pharmaceuticals Inc. (VRCA)

6.89 +0.24 (+3.56%)
As of 1:56 PM EDT. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for VRCA

Recent News: VRCA

View More
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?

Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
Zacks yesterday
Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss

Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss
Simply Wall St. 23 days ago
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire 24 days ago
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA

Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA
GlobeNewswire last month
When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Become Profitable?

When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Become Profitable?
Simply Wall St. last month
Verrica Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Verrica Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Simply Wall St. last month
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q4 2023 Earnings Call Transcript

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q4 2023 Earnings Call Transcript
Insider Monkey last month

Verrica Pharmaceuticals Inc (VRCA) Reports Fourth Quarter and Full-Year 2023 Financial Results
GuruFocus.com last month
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
GlobeNewswire last month
Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference

Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
GlobeNewswire last month
Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024

Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024
GlobeNewswire 2 months ago
Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition

Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition
GlobeNewswire 2 months ago
View More

Related Tickers

TSHA Taysha Gene Therapies, Inc.
2.4450
+6.30%
 
SCPH scPharmaceuticals Inc.
4.5300
+4.15%
 
LPCN Lipocine Inc.
4.6400
+2.65%
 
SXTP 60 Degrees Pharmaceuticals, Inc.
0.2306
-3.43%
 
SNDX Syndax Pharmaceuticals, Inc.
20.91
+1.65%
 
AVTE Aerovate Therapeutics, Inc.
21.97
+1.85%
 
EDSA Edesa Biotech, Inc.
4.3101
-2.49%
 
LABP Landos Biopharma, Inc.
22.45
+0.45%
 
QTTB Q32 Bio Inc.
28.34
+0.35%
 
ZVRA Zevra Therapeutics, Inc.
4.5900
+1.55%